Hisamitsu Pharmaceutical Co., Inc. (4530) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Ono Pharmaceutical Co., Ltd.

Astellas Pharma, Inc.

Shionogi & Co., Ltd.

Otsuka Holdings Co., Ltd.

Takeda Pharmaceutical Co., Ltd.

Eisai Co., Ltd.

Santen Pharmaceutical Co., Ltd.

Hisamitsu Pharmaceutical Co., Inc.

Kobayashi Pharmaceutical Co., Ltd.

Kyowa Kirin Co., Ltd.

Taisho Pharmaceutical Holdings Co., Ltd.

Why is Hisamitsu Pharmaceutical Co., Inc. ?

Poor long term growth as Net Sales has grown by an annual rate of 2.04% and Operating profit at -3.63% over the last 5 years

Flat results in May 25

CASH AND EQV(HY) Lowest at JPY 247,243 MM
DEBT-EQUITY RATIO (HY) Highest at -42.71 %
INVENTORY TURNOVER RATIO(HY) Lowest at 2.64%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hisamitsu Pharmaceutical Co., Inc. for you?

Low Risk, High Return

Absolute

Risk Adjusted

Volatility

Hisamitsu Pharmaceutical Co., Inc.

-100.0%

507.01

32.59%

Japan Nikkei 225

38.59%

1.45

26.59%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

2.04%

EBIT Growth (5y)

-3.63%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.46

Sales to Capital Employed (avg)

0.55

Tax Ratio

21.89%

Dividend Payout Ratio

30.45%

Pledged Shares

Institutional Holding

0.06%

ROCE (avg)

10.13%

ROE (avg)

5.31%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.25

EV to EBIT

11.58

EV to EBITDA

8.67

EV to Capital Employed

1.45

EV to Sales

1.40

PEG Ratio

0.31

Dividend Yield

0.11%

ROCE (Latest)

12.52%

ROE (Latest)

8.17%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

OBV

Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

ROCE(HY)

Highest at 7.3%

RAW MATERIAL COST(Y)

Fallen by -5.78% (YoY

NET PROFIT(9M)

Higher at JPY 15,528.72 MM

-12What is not working for the Company

CASH AND EQV(HY)

Lowest at JPY 247,243 MM

DEBT-EQUITY RATIO (HY)

Highest at -42.71 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.64%

NET SALES(Q)

Lowest at JPY 34,665 MM

OPERATING PROFIT(Q)

Lowest at JPY 5,056 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 14.59 %

PRE-TAX PROFIT(Q)

Lowest at JPY 3,791 MM

NET PROFIT(Q)

Lowest at JPY 2,564 MM

EPS(Q)

Lowest at JPY 35.1

Here's what is working for Hisamitsu Pharmaceutical Co., Inc.

Raw Material Cost

Fallen by -5.78% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hisamitsu Pharmaceutical Co., Inc.

Pre-Tax Profit

At JPY 3,791 MM has Fallen at -45.18%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (JPY MM)

Net Sales

Lowest at JPY 34,665 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (JPY MM)

Operating Profit

Lowest at JPY 5,056 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (JPY MM)

Operating Profit Margin

Lowest at 14.59 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at JPY 3,791 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Net Profit

Lowest at JPY 2,564 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (JPY MM)

Net Profit

Fallen at -46.46%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (JPY MM)

EPS

Lowest at JPY 35.1

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (JPY)

Cash and Eqv

Lowest at JPY 247,243 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -42.71 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 2.64%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio